Articles

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria;Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria;Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria;Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria;Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria;Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria
Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria
Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Central European Institute of Technology (CEITEC), Center of Molecular Medicine, Masaryk University, Brno, Czech Republic
Department of Chemistry, University of Toronto Mississauga, Mississauga, Ontario, Canada
Karl Landsteiner Institute of Dermatological Research, St. Poelten, Austria and Department of Dermatology and Venereology, Karl Landsteiner University for Health Sciences, St. Poelten, Austria
Department of Clinical Pathology, Karl Landsteiner University of Health Sciences, St. Poelten, Austria
Institute of Pathology and Microbiology, Wilheminenspital, Vienna, Austria
Department of Internal Medicine – Hematology and Oncology, Faculty of Medicine Masaryk University and University Hospital Brno, Brno, Czech Republic
Central European Institute of Technology (CEITEC), Center of Molecular Medicine, Masaryk University, Brno, Czech Republic;Department of Internal Medicine – Hematology and Oncology, Faculty of Medicine Masaryk University and University Hospital Brno, Brno, Czech Republic
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria
Biomodels Austria, University of Veterinary Medicine Vienna, Vienna, Austria;IFA-Tulln, University of Natural Resources and Applied Life Sciences, Tulln, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria;Institute of Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria;Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria;Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria
Central European Institute of Technology (CEITEC), Center of Molecular Medicine, Masaryk University, Brno, Czech Republic
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria
Institute of Laboratory Animal Science, University of Veterinary Medicine Vienna, Vienna, Austria
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria;Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria;Medical University of Vienna, Vienna, Austria
Vol. 105 No. 2 (2020): February, 2020 https://doi.org/10.3324/haematol.2019.216986